Ambu A/S (AMBBY) Stock Price, News & Analysis

Company Overview

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

Key Stats

• Today's Range: $19.01 to $19.01
• 50-Day Range: $13.02 to $19.14
• 52-Week Range: $13.02 to $22.65
• Volume: 125 shs
• Average Volume: 147 shs
• Market Capitalization: $4.47 billion
• P/E Ratio: 158.38
• Dividend Yield: 0.11%
• Price Target: N/A
• Consensus Rating: N/A

AMBBY Stock Analysis - Frequently Asked Questions

How have AMBBY shares performed this year?

Ambu A/S's stock was trading at $13.02 at the beginning of the year. Since then, AMBBY shares have increased by 46.0% and is now trading at $19.0050.
View the best growth stocks for 2025 here.

How were Ambu A/S's earnings last quarter?

Ambu A/S (OTCMKTS:AMBBY) announced its earnings results on Tuesday, November, 5th. The company reported ($0.08) earnings per share (EPS) for the quarter. The company had revenue of $204.32 million for the quarter. Ambu A/S had a net margin of 4.30% and a trailing twelve-month return on equity of 4.11%.

How do I buy shares of Ambu A/S?

Shares of AMBBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 11/05/2024
• Ex-Dividend for 12/23 Dividend: 12/06/2024
• Dividend Payable: 12/23/2024
• Today: 1/29/2025
• Next Earnings (Estimated): 1/30/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Holding & other investment offices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:AMBBY
• Previous Symbol: OTCMKTS:AMBBY
• CUSIP: N/A
• CIK: N/A
• Web: www.ambu.com
• Phone: (457) 225-2000
• Fax: N/A
• Employees: 5,196
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.12
• Trailing P/E Ratio: 158.38
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $34.17 million
• Net Margins: 4.30%
• Pretax Margin: 5.56%
• Return on Equity: 4.11%
• Return on Assets: 3.24%

Debt

• Debt-to-Equity Ratio: 0.09
• Current Ratio: 2.49
• Quick Ratio: 1.47

Sales & Book Value

• Annual Sales: $783.76 million
• Price / Sales: 5.70
• Cash Flow: $0.58 per share
• Price / Cash Flow: 32.83
• Book Value: $3.46 per share
• Price / Book: 5.49

Miscellaneous

• Outstanding Shares: 234,974,000
• Free Float: N/A
• Market Cap: $4.47 billion
• Optionable: Not Optionable
• Beta: N/A